Literature DB >> 16439210

The evi5 oncogene regulates cyclin accumulation by stabilizing the anaphase-promoting complex inhibitor emi1.

Adam G Eldridge1, Alexander V Loktev, David V Hansen, Emmy W Verschuren, Julie D R Reimann, Peter K Jackson.   

Abstract

The anaphase-promoting complex/cyclosome (APC/C) inhibitor Emi1 controls progression to S phase and mitosis by stabilizing key APC/C ubiquitination substrates, including cyclin A. Examining Emi1 binding proteins, we identified the Evi5 oncogene as a regulator of Emi1 accumulation. Evi5 antagonizes SCF(betaTrCP)-dependent Emi1 ubiquitination and destruction by binding to a site adjacent to Emi1's DSGxxS degron and blocking both degron phosphorylation by Polo-like kinases and subsequent betaTrCP binding. Thus, Evi5 functions as a stabilizing factor maintaining Emi1 levels in S/G2 phase. Evi5 protein accumulates in early G1 following Plk1 destruction and is degraded in a Plk1- and ubiquitin-dependent manner in early mitosis. Ablation of Evi5 induces precocious degradation of Emi1 by the Plk/SCF(betaTrCP) pathway, causing premature APC/C activation; cyclin destruction; cell-cycle arrest; centrosome overduplication; and, finally, mitotic catastrophe. We propose that the balance of Evi5 and Polo-like kinase activities determines the timely accumulation of Emi1 and cyclin, ensuring mitotic fidelity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16439210     DOI: 10.1016/j.cell.2005.10.038

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  40 in total

Review 1.  Amphibians as research models for regenerative medicine.

Authors:  Fengyu Song; Bingbing Li; David L Stocum
Journal:  Organogenesis       Date:  2010 Jul-Sep       Impact factor: 2.500

2.  A non-synonymous single-nucleotide polymorphism associated with multiple sclerosis risk affects the EVI5 interactome.

Authors:  Alessandro Didonna; Noriko Isobe; Stacy J Caillier; Kathy H Li; Alma L Burlingame; Stephen L Hauser; Sergio E Baranzini; Nikolaos A Patsopoulos; Jorge R Oksenberg
Journal:  Hum Mol Genet       Date:  2015-10-03       Impact factor: 6.150

3.  Unique ability of pandemic influenza to downregulate the genes involved in neuronal disorders.

Authors:  Esmaeil Ebrahimie; Zahra Nurollah; Mansour Ebrahimi; Farhid Hemmatzadeh; Jagoda Ignjatovic
Journal:  Mol Biol Rep       Date:  2015-08-06       Impact factor: 2.316

4.  Identification of Rab11 as a small GTPase binding protein for the Evi5 oncogene.

Authors:  Christopher J Westlake; Jagath R Junutula; Glenn C Simon; Manohar Pilli; Rytis Prekeris; Richard H Scheller; Peter K Jackson; Adam G Eldridge
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-17       Impact factor: 11.205

5.  Loss of Emi1-dependent anaphase-promoting complex/cyclosome inhibition deregulates E2F target expression and elicits DNA damage-induced senescence.

Authors:  Emmy W Verschuren; Kenneth H Ban; Marilyn A Masek; Norman L Lehman; Peter K Jackson
Journal:  Mol Cell Biol       Date:  2007-09-17       Impact factor: 4.272

Review 6.  Regulation of APC/C activators in mitosis and meiosis.

Authors:  Jillian A Pesin; Terry L Orr-Weaver
Journal:  Annu Rev Cell Dev Biol       Date:  2008       Impact factor: 13.827

7.  Rab11 endosomes contribute to mitotic spindle organization and orientation.

Authors:  Heidi Hehnly; Stephen Doxsey
Journal:  Dev Cell       Date:  2014-02-20       Impact factor: 12.270

8.  Regulation of late G1/S phase transition and APC Cdh1 by reactive oxygen species.

Authors:  Courtney G Havens; Alan Ho; Naohisa Yoshioka; Steven F Dowdy
Journal:  Mol Cell Biol       Date:  2006-06       Impact factor: 4.272

9.  Stem cell exhaustion due to Runx1 deficiency is prevented by Evi5 activation in leukemogenesis.

Authors:  Bindya Jacob; Motomi Osato; Namiko Yamashita; Chelsia Qiuxia Wang; Ichiro Taniuchi; Dan R Littman; Norio Asou; Yoshiaki Ito
Journal:  Blood       Date:  2009-12-14       Impact factor: 22.113

10.  Proteomic analysis of blastema formation in regenerating axolotl limbs.

Authors:  Nandini Rao; Deepali Jhamb; Derek J Milner; Bingbing Li; Fengyu Song; Mu Wang; S Randal Voss; Mathew Palakal; Michael W King; Behnaz Saranjami; Holly L D Nye; Jo Ann Cameron; David L Stocum
Journal:  BMC Biol       Date:  2009-11-30       Impact factor: 7.431

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.